Evotec SE (EVO) EBITDA (2009 - 2025)

Evotec SE (EVO) reported EBITDA of $67514.5 for Q4 2025, up 121.69% on a YoY basis from $30455.0 in Q4 2024, and up 229.77% sequentially from -$52025.3 in Q3 2025.

Evotec SE (EVO) EBITDA (2009 - 2025) Analysis & Trends

Evotec SE (EVO) has 9 years of EBITDA data on file, last reported at $67514.5 in Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 121.69% year-over-year to $67514.5; the trailing twelve-month figure through Dec 2025 stood at $16849.1 (down 75.46% YoY), and the FY2025 full-year result was $61927.1, up 156.42% from the prior year.
  • EBITDA grew to $67514.5 in Q4 2025, from -$52025.3 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $80176.3 in Q4 2021 to a low of -$52025.3 in Q3 2025.
  • A 5-year average of $17042.0 and a median of $20918.2 in 2021 frame the typical range for EBITDA.
  • Across the five-year window, EBITDA plunged 882.27% in 2023 and surged 121.69% in 2025, its largest moves.
  • Tracing EVO's EBITDA over 5 years: stood at $80176.3 in 2021, then tumbled by 43.25% to $45503.0 in 2022, then increased by 18.73% to $54024.0 in 2023, then sank by 43.63% to $30455.0 in 2024, then soared by 121.69% to $67514.5 in 2025.
  • Business Quant data shows EVO's EBITDA at $67514.5 in Q4 2025, -$52025.3 in Q3 2025, and $30455.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 325.80 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 291.00 Mn
10 Evotec SE 351.60 Mn 351.08 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 67,514.52
Sep 30, 2025 -52,025.29
Dec 31, 2024 30,454.97
Sep 30, 2024 -29,095.13
Dec 31, 2023 54,024.02
Sep 30, 2023 13,266.65
Jun 30, 2023 -39,514.89
Dec 31, 2022 45,503.03
Sep 30, 2022 13,640.94
Jun 30, 2022 -4,022.80
Mar 31, 2022 21,169.53
Dec 31, 2021 80,176.35
Sep 30, 2021 20,918.20
Jun 30, 2021 8,162.55
Mar 31, 2021 25,457.61
Dec 31, 2020 127,123.14
Sep 30, 2020 21,663.16
Dec 31, 2019 69.41 Mn
Sep 30, 2010 867.74
Jun 30, 2010 2,315.10